-
Revolutionary stem cell treatment promises cure for Type 1 diabetes patients
-
This discovery opens the door wide to new possibilities in regenerative medicine, which could change the face of healthcare in the near future and reshape our understanding of how to treat intractable
The announcement of a successful innovative treatment using stem cells for a Chinese woman with Type 1 diabetes has sparked a wave of hope and optimism among millions of patients worldwide. This pioneering medical discovery, revealed by the British newspaper "Daily Mail," paves the way for a definitive treatment for one of the most widespread and challenging chronic diseases.
The new technique revolves around reshaping cells extracted from the patient's own body, where they were transformed into specialized stem cells. These cells were later used to grow clusters of "islets," hormone-producing cells in the pancreas and liver that play a vital role in regulating blood sugar levels. Researchers reported that the 25-year-old patient, residing in Tianjin, successfully produced self-insulin efficiently for over a year.
Commenting on this development, Dr. Amani Kamal Abdel Hamid, Professor of Endocrinology and Diabetes and Head of the Endocrinology and Diabetes Unit at Mansoura University Children's Hospital, in an exclusive interview with "Al Arabiya.net" and "Al Hadath.net," explained that this treatment, if proven effective, will have a profound impact on millions of patients in Egypt and worldwide.
She added that stem cell therapy has been the focus of medical research for a while, pointing to the need for more extensive trials to confirm its effectiveness.
Dr. Amani emphasized that if the experiment succeeds scientifically and is applied to a large number of patients, it will cause a radical shift in the field of diabetes treatment. However, she cautioned that other factors such as treatment cost and patients' ability to afford it compared to traditional medications must be taken into consideration.
She explained that stem cell therapy relies on mutated cells that mimic the function of insulin-producing cells in the body, leading to stable insulin secretion. She concluded by saying that the success of this technique would be a great achievement benefiting millions of patients in Egypt and around the world.
This discovery opens new horizons in the field of regenerative medicine and promises the possibility of overcoming one of the most widespread chronic diseases. However, challenges remain regarding treatment cost and the possibility of widespread implementation, which calls for more research and development in this promising field.
Levant-Agencies
